Shareholder alert: pomerantz law firm announces the filing of a class action against regeneron pharmaceuticals, inc. – regn

New york, ny / access newswire / january 18, 2025 / pomerantz llp announces that a class action lawsuit has been filed against regeneron pharmaceuticals, inc. ("regeneron" or the "company") (nasdaq:regn). such investors are advised to contact danielle peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-pomlaw), toll-free, ext.

REGN Ratings Summary

REGN Quant Ranking